arrow
R

Ryan M. Esquejo

Pfizer
H指数:10
被引数:1,397

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61; an Orphan G Protein-Coupled Receptor

发现强效且能透过血脑屏障的GPR61反向激动剂;一种孤儿G蛋白偶联受体

2026-03-150
PRE
GIPR signaling modulates PYY-induced hypophagia and malaise in rodents

GIPR信号通路调节啮齿动物中PYY诱导的食欲减退和不适感。

2026-02-100
OAAI
Uncovering the role of Gpr45 in obesity regulation

揭示Gpr45在肥胖调控中的作用

2025-05-290
OA
Chronic UCN2 treatment desensitizes CRHR2 and improves insulin sensitivity
2023-07-043
OAAI
AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism

AMPK激活足以增加骨骼肌葡萄糖摄取和糖原合成,但不是收缩介导的葡萄糖代谢增加所必需的

HELIYON
IF3.6
2022-10-016
OAAI
GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates

GDF-15中和减轻了基于铂的化疗引起的小鼠和非人灵长类动物的呕吐,厌食和体重减轻

2020-12-0199
OAAI
Growth differentiation factor 15 (GDF-15) inhibition attenuates platinum-based chemotherapy-induced emesis, anorexia and weight loss and increases survival
2020-08-150
PRE
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models

在啮齿动物和灵长类动物临床前模型中,用PF-06409577激活肝脏AMPK纠正NAFLD并降低胆固醇

2018-05-01109
OAAI
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice

骨骼肌AMPK的激活促进非人灵长类动物和小鼠的葡萄糖处置和葡萄糖降低

2017-05-01219
OAAI